Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Protocol for the Treatment of Adults Aged </= 60 Years With De Novo Acute Myeloblastic Leukaemia or Secondary AML or RAEB-T (AML 01/99 Trial)

NCT00209833 is registered in ClinicalTrials.gov with Hannover Medical School as lead sponsor.

NCT NCT00209833
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00209833 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Protocol for the Treatment of Adults Aged </= 60 Years With De Novo Acute Myeloblastic Leukaemia or Secondary AML or RAEB-T (AML 01/99 Trial)
Lead sponsor
Hannover Medical School
Phase
Phase 2/3
Overall status
Unknown status
Start date
January 31, 1999
Completion date
September 30, 2005
Enrollment
200
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

de novo akute myeloid leukemia (aml), refractory anemia with excess of blasts in transformation, secondary acute myeloid leukemia (aml)